The American Chronic Pain Society joined with Pfizer to conduct a survey on the prevalence of symptoms of diabetic peripheral neuropathy in patients with diabetes. Their results show that nerve pain is reported in about twice as many patients as estimated by healthcare providers. Additionally, the survey found gaps in communication between doctors, nurses, and patients about the disease. They have spearheaded a new program, Diabetic Nerve Pain: Starting the Dialogue to provide resources for patients and healthcare providers. READ MORE
Source: NationalPainReport.com